Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33)

The summary for the Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33): This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the advanced development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes technologies that address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and storage of cancer-relevant biospecimens. This FOA solicits R33 applications where proof-of-principle for the emerging technology or methodology has been provided with supportive preliminary data demonstrating a novel capability for maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or cancer health disparities. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this FOA and will not be reviewed.
Federal Grant Title: Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-16-004
Type of Funding: Grant
CFDA Numbers: 93.394
CFDA Descriptions: Cancer Detection and Diagnosis Research
Current Application Deadline: Sep 26, 2016
Original Application Deadline: Sep 26, 2016
Posted Date: Dec 8, 2015
Creation Date: Dec 9, 2015
Archive Date: Oct 27, 2016
Total Program Funding: $800,000
Maximum Federal Grant Award: $300,000
Minimum Federal Grant Award: none
Expected Number of Awards: 2
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Independent school districts
State governments
Native American tribal governments (Federally recognized)
Private institutions of higher education
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
City or township governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Special district governments
Additional Information on Eligibility
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-16-004.html
Grant Announcement Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Ima...
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R4...
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R4...
Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collab...
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies ...
Image-Guided Cancer Interventions (STTR [R41/R42])
An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44)
In Vivo Cancer Imaging Exploratory/Developmental Grants
More Grants from the National Institutes of Health
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology an...
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology an...
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology an...
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com